1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Cormorant Asset Management, LLC Buys Forma Therapeutics Holdings Inc, Avidity Biosciences Inc, Immunovant Inc, Sells Principia Biopharma Inc, Mirati Therapeutics Inc, Satsuma Pharmaceuticals Inc

Boston, MA, based Investment company Cormorant Asset Management, LLC (Current Portfolio) buys Forma Therapeutics Holdings Inc, Avidity Biosciences Inc, Immunovant Inc, Trillium Therapeutics Inc, Zymeworks Inc, sells Principia Biopharma Inc, Mirati Therapeutics Inc, Satsuma Pharmaceuticals Inc, NextCure Inc, MyoKardia Inc during the 3-months ended 2020Q3, according to the most recent filings of the investment company, Cormorant Asset Management, LLC. As of 2020Q3, Cormorant Asset Management, LLC owns 85 stocks with a total value of $2.5 billion. These are the details of the buys and sells.

For the details of Cormorant Asset Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/cormorant+asset+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Cormorant Asset Management, LLC
  1. Turning Point Therapeutics Inc (TPTX) - 2,442,297 shares, 8.46% of the total portfolio. Shares reduced by 10.78%
  2. SSGA SPDR S&P 500 (SPY) - 500,000 shares, 6.64% of the total portfolio.
  3. Forma Therapeutics Holdings Inc (FMTX) - 3,379,373 shares, 6.60% of the total portfolio. New Position
  4. Revolution Medicines Inc (RVMD) - 2,640,177 shares, 3.64% of the total portfolio. Shares added by 0.13%
  5. BridgeBio Pharma Inc (BBIO) - 2,265,762 shares, 3.37% of the total portfolio. Shares reduced by 12.54%
New Purchase: Forma Therapeutics Holdings Inc (FMTX)

Cormorant Asset Management, LLC initiated holding in Forma Therapeutics Holdings Inc. The purchase prices were between $32.95 and $50.25, with an estimated average price of $40.52. The stock is now traded at around $38.53. The impact to a portfolio due to this purchase was 6.6%. The holding were 3,379,373 shares as of .

New Purchase: Avidity Biosciences Inc (RNA)

Cormorant Asset Management, LLC initiated holding in Avidity Biosciences Inc. The purchase prices were between $23.35 and $35.94, with an estimated average price of $28.87. The stock is now traded at around $29.66. The impact to a portfolio due to this purchase was 2.76%. The holding were 2,514,546 shares as of .

New Purchase: Immunovant Inc (IMVT)

Cormorant Asset Management, LLC initiated holding in Immunovant Inc. The purchase prices were between $22.61 and $38.9, with an estimated average price of $30.07. The stock is now traded at around $48.35. The impact to a portfolio due to this purchase was 2.28%. The holding were 1,637,951 shares as of .

New Purchase: Trillium Therapeutics Inc (TRIL)

Cormorant Asset Management, LLC initiated holding in Trillium Therapeutics Inc. The purchase prices were between $6.56 and $16, with an estimated average price of $9.93. The stock is now traded at around $17.78. The impact to a portfolio due to this purchase was 1.41%. The holding were 2,500,000 shares as of .

New Purchase: Albireo Pharma Inc (ALBO)

Cormorant Asset Management, LLC initiated holding in Albireo Pharma Inc. The purchase prices were between $23.19 and $41.61, with an estimated average price of $29.06. The stock is now traded at around $35.18. The impact to a portfolio due to this purchase was 0.93%. The holding were 700,000 shares as of .

New Purchase: Otonomy Inc (OTIC)

Cormorant Asset Management, LLC initiated holding in Otonomy Inc. The purchase prices were between $3.16 and $4.36, with an estimated average price of $3.76. The stock is now traded at around $4.32. The impact to a portfolio due to this purchase was 0.52%. The holding were 3,241,800 shares as of .

Added: Zymeworks Inc (ZYME)

Cormorant Asset Management, LLC added to a holding in Zymeworks Inc by 109.09%. The purchase prices were between $29.21 and $46.58, with an estimated average price of $34.32. The stock is now traded at around $47.16. The impact to a portfolio due to this purchase was 1.11%. The holding were 1,150,000 shares as of .

Added: Omeros Corp (OMER)

Cormorant Asset Management, LLC added to a holding in Omeros Corp by 80.18%. The purchase prices were between $9.57 and $21.32, with an estimated average price of $12.87. The stock is now traded at around $11.44. The impact to a portfolio due to this purchase was 0.89%. The holding were 5,000,000 shares as of .

Added: BioNTech SE (BNTX)

Cormorant Asset Management, LLC added to a holding in BioNTech SE by 85.71%. The purchase prices were between $57.81 and $104.17, with an estimated average price of $71.42. The stock is now traded at around $104.07. The impact to a portfolio due to this purchase was 0.41%. The holding were 325,000 shares as of .

Added: Akero Therapeutics Inc (AKRO)

Cormorant Asset Management, LLC added to a holding in Akero Therapeutics Inc by 45.06%. The purchase prices were between $30.79 and $39.92, with an estimated average price of $34.88. The stock is now traded at around $28.93. The impact to a portfolio due to this purchase was 0.33%. The holding were 859,550 shares as of .

Added: Theravance Biopharma Inc (TBPH)

Cormorant Asset Management, LLC added to a holding in Theravance Biopharma Inc by 550.07%. The purchase prices were between $14.79 and $22.49, with an estimated average price of $18.74. The stock is now traded at around $17.21. The impact to a portfolio due to this purchase was 0.32%. The holding were 650,072 shares as of .

Added: Galapagos NV (GLPG)

Cormorant Asset Management, LLC added to a holding in Galapagos NV by 31.21%. The purchase prices were between $122.47 and $213.56, with an estimated average price of $166.57. The stock is now traded at around $124.67. The impact to a portfolio due to this purchase was 0.17%. The holding were 130,000 shares as of .

Sold Out: Principia Biopharma Inc (PRNB)

Cormorant Asset Management, LLC sold out a holding in Principia Biopharma Inc. The sale prices were between $56 and $101.07, with an estimated average price of $88.57.

Sold Out: Satsuma Pharmaceuticals Inc (STSA)

Cormorant Asset Management, LLC sold out a holding in Satsuma Pharmaceuticals Inc. The sale prices were between $3.85 and $28.47, with an estimated average price of $20.25.

Sold Out: NextCure Inc (NXTC)

Cormorant Asset Management, LLC sold out a holding in NextCure Inc. The sale prices were between $8.15 and $21.17, with an estimated average price of $10.38.

Sold Out: ARYA Sciences Acquisition Corp II (ARYBU)

Cormorant Asset Management, LLC sold out a holding in ARYA Sciences Acquisition Corp II. The sale prices were between $10.71 and $12.49, with an estimated average price of $11.34.

Sold Out: X4 Pharmaceuticals Inc (XFOR)

Cormorant Asset Management, LLC sold out a holding in X4 Pharmaceuticals Inc. The sale prices were between $6.09 and $9.15, with an estimated average price of $8.01.

Reduced: Mirati Therapeutics Inc (MRTX)

Cormorant Asset Management, LLC reduced to a holding in Mirati Therapeutics Inc by 45%. The sale prices were between $113.26 and $167.27, with an estimated average price of $136.56. The stock is now traded at around $226.89. The impact to a portfolio due to this sale was -1.07%. Cormorant Asset Management, LLC still held 275,000 shares as of .



Here is the complete portfolio of Cormorant Asset Management, LLC. Also check out:

1. Cormorant Asset Management, LLC's Undervalued Stocks
2. Cormorant Asset Management, LLC's Top Growth Companies, and
3. Cormorant Asset Management, LLC's High Yield stocks
4. Stocks that Cormorant Asset Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)